Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 45.9 Cr.
- Current Price ₹ 19.6
- High / Low ₹ 39.1 / 16.0
- Stock P/E 39.6
- Book Value ₹ 43.8
- Dividend Yield 0.00 %
- ROCE 2.53 %
- ROE 1.67 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.45 times its book value
- Debtor days have improved from 99.6 to 60.4 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 18.3%
- Company has a low return on equity of 1.67% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
- Promoter holding has decreased over last 3 years: -16.6%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Food - Processing - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|
42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 70.28 | |
30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 67.04 | |
Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.24 |
OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 4.61% |
0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | |
Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.09 |
Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.46 |
Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.70 |
Tax % | 0.39% | 25.00% | 40.00% | 31.82% | 33.03% | |
10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | |
EPS in Rs | 6.42 | 0.25 | 0.20 | 0.18 | 0.73 | 0.55 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 21% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 56% |
TTM: | -29% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -6% |
3 Years: | -18% |
1 Year: | -25% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|
Equity Capital | 15.71 | 15.71 | 17.04 | 20.38 | 20.98 |
Reserves | 60.91 | 61.23 | 64.52 | 76.53 | 78.18 |
1.03 | 1.25 | 1.61 | 1.90 | 1.27 | |
14.61 | 12.44 | 13.62 | 9.24 | 12.75 | |
Total Liabilities | 92.26 | 90.63 | 96.79 | 108.05 | 113.18 |
19.87 | 18.53 | 16.85 | 15.69 | 15.04 | |
CWIP | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
72.32 | 72.10 | 79.94 | 92.36 | 98.14 | |
Total Assets | 92.26 | 90.63 | 96.79 | 108.05 | 113.18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
2.68 | 0.22 | -0.57 | -6.76 | -12.55 | |
-1.94 | -0.07 | -0.05 | 0.27 | -0.30 | |
-1.77 | -0.37 | 0.07 | 5.26 | 14.04 | |
Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 134.74 | 141.07 | 97.21 | 60.44 | |
Inventory Days | 890.81 | 1,182.75 | 683.64 | 445.05 | |
Days Payable | 112.09 | 147.78 | 123.28 | 41.68 | |
Cash Conversion Cycle | 913.46 | 1,176.04 | 657.58 | 463.81 | |
Working Capital Days | 545.99 | 603.01 | 509.48 | 478.54 | |
ROCE % | 5.62% | 0.68% | 2.53% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
17 Apr - Certificate under Reg 74(5) for the Quarter Ended March 2025
-
Announcement under Regulation 30 (LODR)-Change in Directorate
11 Apr - Appointment of Mr. Mohak Gupta as Executive Director.
-
Board Meeting Outcome for Outcome Of Board Meeting
11 Apr - Conversion of warrants into equity shares and appointment of director.
-
Board Meeting Intimation for Allotment Of Equity Shares
8 Apr - Board meeting to approve equity share allotment.
-
Board Meeting Outcome for Outcome Of Board Meeting
1 Apr - Board approved conversion of warrants into equity shares.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com